Scleroderma News

A speaker at the PFF Summit highlighted recent trials and therapeutic updates for progressive fibrosing interstitial lung disease.

The COVID-19 pandemic brought with it a significant decrease in autoimmunity laboratory testing, first rheumatology visits and diagnoses from 2019 to 2020, according to Italian data published in The Journal of Rheumatology.

Despite a significant decrease in anxiety related to COVID-19, patients with autoimmune rheumatic disease continue to experience frequent interruptions in their medication use, according to survey data presented at ACR Convergence 2021.

Hour-long, virtual exercise classes that cover Pilates, yoga and tai chi are safe and improved health outcomes in patients with musculoskeletal disease, according to data presented at ACR Convergence 2021.

Data presented at ACR Convergence 2021 support the use of life-saving lung transplantation among qualified patients with systemic autoimmune diseases.

Managing oral, ocular and cutaneous complications is critical to optimizing outcomes in conditions ranging from Sjögren’s syndrome to juvenile dermatomyositis, according to a presenter who offered a cross-section of “pearls and myths” at ACR Convergence 2021.

Black patients with systemic sclerosis had multiple poor prognostic features compared with non-Black patients, putting them at higher risk for mortality, according to data presented at ACR Convergence 2021.

A prediction model presented at ACR Convergence 2021 demonstrated that the use of platelet inhibitors could predict a lower probability of digital ulcer occurrence among patients with systemic sclerosis.

Healio announced the launch of Rheum and Boards, a quiz-based, online learning resource for rheumatologists, according to a Healio press release.

Gastroprotective and promotility agents do not appear to prevent clinically apparent systemic sclerosis-associated interstitial lung disease, according to results of a large retrospective cohort study.